United Therapeutics Corporation Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
United Therapeutics Corporation (UTHR) had Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax of -$6.80 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax · last filed 2026-02-25
- 2025-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax -$6.80M.
- 2024-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax -$12.40M.
- 2023-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax -$17.70M.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax -$21.10M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax |
|---|---|
| 2025-12-31 | -$6.80M 10-K · filed 2026-02-25 |
| 2024-12-31 | -$12.40M 10-K · filed 2026-02-25 |
| 2023-12-31 | -$17.70M 10-K · filed 2026-02-25 |
| 2022-12-31 | -$21.10M 10-K · filed 2025-02-26 |
| 2021-12-31 | -$700.00K 10-K · filed 2024-02-21 |
| 2020-12-31 | $5.80M 10-K · filed 2023-02-22 |
| 2019-12-31 | -$1.20M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |